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Inflammation and cardiovascular risk in dialysis patients. terol are reduced [3]. The modulation of the balance
Background. Chronic inflammation, as evidenced by in- between atherogenic proteins, also called emerging new
creased levels of C-reactive protein (CRP), predicts all-cause risk factors or non-traditional risk factors, and antiath-and cardiovascular mortality in hemodialysis patients in short-
erogenic proteins may explain the progressive nature ofterm studies. Whether CRP is also predictive in the long-term
atherosclerosis in the absence of classic, traditional riskfollow-up is unknown.
Methods. We conducted a 4-year follow-up of a cross-sec- factors in dialysis patients. Because the levels of these
tional study in a cohort of 280 stable hemodialysis patients. proteins might undergo continuous modulation [6] by
CRP was determined once at the beginning of the study, and
the acute phase stimuli, it remains unclear for what peri-all-cause as well as cardiovascular mortality was monitored pro-
ods of time these proteins remain predictive in hemodi-spectively.
Results. During follow-up, 123 patients (43.9%) had died, alysis patients.
mostly from cardiovascular events (58.5%) corresponding to an In the present study, we therefore evaluated the 4-year
annual mortality rate of 11%. Overall mortality and cardiovas- predictive power of acute phase proteins and its bestcular mortality were significantly higher in patients with a CRP
known representative, CRP, in a cohort of 280 hemodi-more than 8 mg/L (73% vs. 39% and 87% vs. 55%, respectively).
alysis patients.Multivariate Cox regression analysis demonstrated that age,
CRP, and preexisting cardiovascular disease were the most pow-
erful predictors, but the presence of diabetes, albumin, and BMI
also remained in the model. METHODS
Conclusion. A single determination of CRP is a powerful in-
The study population, baseline examination, samplingdicator of all cause and cardiovascular death even after a fol-
procedure, and laboratory analysis as well as statisticallow-up period of 4 years in patients on hemodialysis treatment.
analysis have been described previously [3]. Briefly, be-
tween September and November 1995, patients from
three outpatient dialysis centers entered the study (130The inflammatory response to a given stimulus can be
women and 150 men, mean age 62.4 13.7 yrs). Patientsevidenced by a number of acute phase proteins; the most
were already on hemodialysis treatment for 55  56established is C-reactive protein (CRP) [1]. CRP is a
months. A follow-up investigation was performed at 12,prominent product of the inflammatory response syn-
24, and 48 months, and the results of the latter evaluationdrome and a marker of overall and cardiovascular death
are reported here. Data from all original 280 hemodialy-in the general population as well as in hemodialysis pa-
tients [2–4]. CRP is elevated 8–10-fold in hemodialysis sis patients could be obtained for analysis of the four-
patients as compared with healthy controls [3–5] and year mortality, and no patient was lost in the follow-up.
appears to be a common feature in chronic renal failure Date and cause of death were evaluated from records
and dialysis patients. Chronic inflammation is linked to and from interviews with the physicans in the outpatient
atherosclerotic cardiovascular disease by a number of dialysis centers. Causes of death were classified as de-
mechanisms and contributes to the high mortality seen scribed previously [3].
in this patient group. Chronic inflammation is accompa-
nied by an increase in serum levels of other important
RESULTSacute phase proteins such as fibrinogen and lipoprotein(a)
which also are atherogenic. On the other hand, levels of The data of the two-year analysis have been reported
anti-atherogenic proteins such as apolipoprotein A-I previously [3]. During the follow-up period of four years,
(ApoA-I) and high density lipoprotein (HDL) choles- 123 out of 280 patients (44%) had died, most from cardio-
vascular events (72 out of 123, 58%), corresponding to
an annual mortality rate of 11%. The death rate curveKey words: C-reactive protein, acute phase response, cardiovascular
disease, hemodialysis. was linear. Patients with diabetes (N  81) had a higher
mortality rate at 4 years (65%) as compared with patients 2002 by the International Society of Nephrology
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higher risk for cardiovascular mortality (87 vs. 50%; P
0.0001) during follow-up than those in the lowest quartile
(less than 3.3 mg/L). Tables 1 and 2 outline univariate
and multivariate stepwise logistic regression process by
the Cox proportional hazards method.
DISCUSSION
This study confirms that inflammation is associated
with an increased overall and cardiovascular mortality
in hemodialysis patients and adds data that prediction
is even maintained after prolonged periods of observa-
tion. It is puzzling and still unresolved how a single and
cross-sectional obtained level of a plasma protein with
a short half life (19 h) may yield such important informa-
tion concerning the long-term prognosis in hemodialysis
patients. Many centers today measure CRP on a routine
basis but no further data are yet available that add knowl-
edge. Pankow et al investigated familial aggregation of
CRP in a large, cross-sectional study conducted in four
US communities. The found a substantial heritability
(35–40%) for CRP levels suggesting that genetic factors
determine, at least in part, a given basal CRP level in
serum [7]. Opinions have been brought forward to use
the mean of multiple measurement, or the delta of two
subsequent measurements, or even the area under the
curve of several measurements. Further studies must
show whether these approaches are superior to a single
measurement in a given patient without infection.
Vascular disease and the predictive value of CRP in
dialysis patients
Apparently we may see exactly the same thing in ure-
mic patients that we see in healthy subjects, only at a higher
level of expression and in a shorter period of time. CRP
measured years before the acute event independently
predicts future risk [3, 4, 8]. In addition, CRP levels are
also associated with an increased intima-media carotid
artery area in predialysis patients [9]. Other negative
and positive acute phase reactants, such as albumin, fi-
brinogen, ApoA-I, and lipoprotein(a) correlate with
Fig. 1. Kaplan-Meier estimates of survival during follow-up with regard CRP, and several of these proteins may be additionalto all-cause (A) and cardiovascular mortality (B) in relation to quartiles
predictors and/or causative factors of the high cardiovas-of serum concentrations of CRP.
cular risk [3, 4, 10]. Because CRP is largely regulated
by circulating levels of interleukin-6 (IL-6), it can be
understood that this cytokine itself predicts mortality in
without diabetes (33%). The relative risk of death in hemodialysis patients and in otherwise healthy elderly
general as well as death caused by cardiovascular events men and women [11–13].
increased with each quartile of baseline concentrations Causes of the chronic inflammatory state in dialysis
of CRP. Figure 1 demonstrates Kaplan-Meier estimates patients. CRP may reflect the consequences of elevated
of survival during follow-up with regard to all-cause (A) levels of proinflammatory cytokines. Several interleukins
and cardiovascular mortality (B) in relation to quartiles are known mediators of the acute phase response. Tumor
of CRP serum concentrations. Patients in the highest necrosis factor- (TNF-) or IL-1 isoforms can stimulate
quartile (more than 15.8 mg/L) had a 2.4-fold higher risk the expression of IL-6 provoking the augmented expres-
sion of the CRP gene in the liver. The rate of hepatic(83 vs. 34%; P  0.0001) for all-cause and a 1.7-fold
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Table 1. Predictors of four-year mortality in the univariate Cox regression analysis
All-cause mortality Cardiovascular mortality
Predictor Units 2 Relative risk P 2 Relative risk P
Age Years 35.09 1.05 0.0001 27.89 1.06 0.0001
Gender Ref.  male 4.94 0.67 0.027 7.14 0.52 0.009
Diabetes Ref.  non-diabetic 28.71 2.57 0.0001 19.74 2.75 0.0001
BMI kg/m2 4.50 0.95 0.034 2.33 0.96 0.127
CRP mg/L 40.02 1.17 0.0001 44.51 1.22 0.0001
Pre-existing CVD Ref.  no CVD 31.39 2.66 0.0001 22.20 2.90 0.0001
Fibrinogen g/L 16.25 1.33 0.0001 15.28 1.43 0.0001
Abbreviations are: 2, the chi-square statistic; BMI, body mass index; CRP, C-reactive protein; CVD, cardiovascular disease.
Table 2. Independent predictors of four-year mortality in hemodialysis patients in the multivariate Cox regression analysis
All-cause mortality Cardiovascular mortality
Predictor Units 2 Relative risk P 2 Relative risk P
Age Years 36.34 1.05 0.0001 30.10 1.07 0.0001
Gender Ref.  male 7.06 0.60 0.010 6.91 0.45 0.003
Diabetes Ref.  non-diabetic 7.97 1.91 0.001 5.63 2.02 0.012
BMI kg/m2 6.81 0.93 0.003 6.95 0.92 0.010
CRP mg/liter 26.27 1.15 0.0001 26.33 1.21 0.0001
Pre-existing CVD Ref.  no CVD 17.01 1.52 0.035 — — NS
2 means the chi-square statistic. Statistical parameters were established after a multivariate stepwise logistic regression process by the Cox proportional hazards
method. Abbreviations are in Table 1.
synthesis of CRP is the sole determinant of its plasma the patients [5, 16]. Lipopolysaccharide, through dialy-
sate contamination, may stimulate cells to secrete cyto-concentration. But which signal has stimulated endothe-
lial cells, monocytes, T-lymphocytes, or mast cells to kines and to initiate an inflammatory reaction. Indeed,
a recent work of Sitter et al [17] suggests that the usesecrete these mediators? We do not yet know, but most
likely enhanced formation of oxygen-free-radicals are of ultrapure dialysis solution will lower plasma CRP in
dialysis patients as compared with conventional dialysis.involved or have a well defined place in this cascade. To
clarify this issue, an intense search for endogenous as The vascular access or the hemodialysis membrane itself
may also be candidates to maintain chronic stimulationwell as exogenous factors is currently under way. Since
patients with chronic renal failure, not yet on mainte- of CRP. The presence of an arteriovenous graft is a sig-
nificant predictor, associated with high CRP and reducednance hemodialysis, or continuous arterial peritoneal di-
alysis (CAPD) patients exhibit a similar degree of eleva- albumin [6]. Schindler et al [5] investigated the impact
of hemodialysis using cuprophane, polyamide, and poly-tion in CRP levels [9], probably factors unrelated to the
hemodialysis procedure but more related to accumula- carbonate membranes in a crossover design on serum
levels of IL-1 receptor antagonist and CRP in 18 patients.tion of toxins are more likely to play the predominant
role. In peritoneal dialysis (PD) patients, peritoneal Dialysis with cuprophane significantly stimulated the
acute phase response as compared with the more bio-transport rate during the first year of treatment is linked
with inflammation and declining RRF. It is possible that compatible membranes.
Does oxidative stress cause inflammation? Compellinginflammation may cause both an increase in peritoneal
transport rate and a decline in RRF, or that the decline evidence now exists that dialysis patients are exposed to
enhanced oxidative stress. Oxidative stress is initiatedin RRF further aggravates inflammation because of less
efficient removal of cytokines [14]. Further studies by the generation of oxygen free radicals, mainly in tissue
and probably in the circulation. The most potent and soshould investigate at what stages of declining renal func-
tion the cascade of inflammation is turned on. These far best investigated O2-generating proteins are oxida-
tively modified lipoproteins, mainly oxidized (ox)-LDL.studies should be designed in order to control for a maxi-
mum of confounding factors, and they should include A similar and comparable inflammatory milieu may be
created by advanced glycation and oxidaton end productsrepeated measurements during a longitudinal follow-up.
Most ideally, the intervention of a potent antioxidant (AGEs, AOPPs). Both molecules, oxLDL and AGEs
may be potent stimulators of oxygen-free radicals viasuch as an ACE-inhibitor or a statin is appreciated [15].
It has been proposed that the dialysis procedure per an NADP/NADPH-dependent process. Oxidative and
carbonyl stress may stimulate cells and the endotheliumse may be responsible for the inflammatory reaction in
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